Diamedica Therapeutics Stock Price on November 4, 2020
| DMAC Stock | USD 2.45 0.03 1.24% |
Below is the normalized historical share price chart for DiaMedica Therapeutics extending back to January 04, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of DiaMedica Therapeutics stands at 2.45, as last reported on the 24th of April, with the highest price reaching 2.56 and the lowest price hitting 2.41 during the day.
If you're considering investing in DiaMedica Stock, it is important to understand the factors that can impact its price. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0294, which denotes the company had a -0.0294% return per unit of standard deviation over the last 3 months. DiaMedica Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm DiaMedica Therapeutics' Coefficient Of Variation of (2,108), mean deviation of 2.73, and Standard Deviation of 3.57 to check the risk estimate we provide.
At present, DiaMedica Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 56.9 M, whereas Stock Based Compensation is forecasted to decline to about 876.3 K. . As of April 24, 2024, Price To Sales Ratio is expected to decline to 49.24. In addition to that, Price Earnings Ratio is expected to decline to -5.01. DiaMedica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 2008 | 200 Day MA 2.8174 | 50 Day MA 2.8138 | Beta 1.741 |
DiaMedica |
Sharpe Ratio = -0.0294
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DMAC |
Estimated Market Risk
| 3.49 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average DiaMedica Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DiaMedica Therapeutics by adding DiaMedica Therapeutics to a well-diversified portfolio.
Price Book 1.8029 | Book Value 1.345 | Enterprise Value 39.4 M | Enterprise Value Ebitda (1.86) | Shares Float 23.8 M |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About DiaMedica Therapeutics Stock history
DiaMedica Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DiaMedica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DiaMedica Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DiaMedica Therapeutics stock prices may prove useful in developing a viable investing in DiaMedica Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 32.6 M | 34.2 M | |
| Net Loss | -12.2 M | -11.6 M |
DiaMedica Therapeutics Quarterly Net Working Capital |
|
DiaMedica Therapeutics Stock Technical Analysis
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
DiaMedica Therapeutics Period Price Range
DiaMedica Therapeutics April 24, 2024 Market Strength
Market strength indicators help investors to evaluate how DiaMedica Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DiaMedica Therapeutics shares will generate the highest return on investment. By undertsting and applying DiaMedica Therapeutics stock market strength indicators, traders can identify DiaMedica Therapeutics entry and exit signals to maximize returns
DiaMedica Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for DiaMedica Therapeutics' price direction in advance. Along with the technical and fundamental analysis of DiaMedica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DiaMedica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.Note that the DiaMedica Therapeutics information on this page should be used as a complementary analysis to other DiaMedica Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for DiaMedica Stock analysis
When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is DiaMedica Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Return On Assets (0.30) | Return On Equity (0.47) |
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.